This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-.

## StatPearls [Internet].

Show details## Introduction

In research, statistical significance is a measure of the probability of the null hypothesis being true compared to the acceptable level of uncertainty regarding the true answer. If we break apart a study design, we can better understand statistical significance.[1][2][3][4][5][6][7]

When creating a study, the researcher has to start with a hypothesis; that is, they must have some idea of what they think the outcome may be. We will use the example of a new medication to lower blood pressure. The researcher hypothesizes that the new medication lowers systolic blood pressure by at least 10 mmHg compared to not taking the new medication. The hypothesis can be then stated, "Taking the new medication will lower systolic blood pressure by at least 10 mmHg compared to not taking the medication." In science, researchers can never prove any statement as there are infinite alternatives as to why the outcome may have occurred. They can only try to disprove a specific hypothesis. The researcher must then formulate a question they can disprove while coming to their conclusion that the new medication lowers systolic blood pressure. The hypothesis, to be disproven, is the null hypothesis and typically the inverse statement of the hypothesis. Thus, the null hypothesis for our researcher would be, "Taking the new medication will not lower systolic blood pressure by at least 10 mmHg compared to not taking the new medication." The researcher now has the null hypothesis for the research and must next specify the significance level or level of acceptable uncertainty.

Even when disproving a hypothesis, the researcher will not be 100% certain of the outcome. The researcher must then settle for some level of confidence or the significance level for which they do want to be correct. The significance level is given the Greek letter alpha and specified as the probability the researcher is willing to be incorrect. Our researcher wants to be correct about their outcome 95% of the time, or the researcher is willing to be incorrect 5% of the time. Probabilities are stated as decimals, with 1.0 being completely positive (100%) and 0 being completely negative (0%). Thus, the researcher who wants to be 95% sure about the outcome of their study is willing to be wrong 5% of the time about the study result. The alpha is the decimal expression of how much they are willing to be wrong. For the current example, the alpha is 0.05. We now have the level of uncertainty the researcher is willing to accept (alpha or significance level) of 0.05 or 5% chance they are not correct about the outcome of the study.

Now the researcher can perform their research. In the example, the researcher would give some individuals the new medication and other individuals no medication. The researcher then looks to see how the blood pressure changes after receiving the new medication and performs a statistical analysis of the results to obtain a p-value (probability value). There are numerous different tests used in research that can provide a p-value. It is imperative to use the correct statistical analysis tool when calculating the p-value. If the researchers use the wrong test, the p-value will not be accurate, and this result can mislead the researcher. A p-value is the probability under a specified statistical model that a statistical summary of the data (e.g., the sample mean difference between two compared groups) would be equal to or more extreme than its observed value. In our example, the researcher found blood pressure did tend to decrease after taking the new medication. The researcher then used the help of their statistician to perform the correct analysis and arrives at a p-value of 0.02 for the decrease in blood pressure for those taking the new medication versus those not taking the new medication. Our researcher now has the three required pieces of information to look at statistical significance: the null hypothesis, the significance level, and the p-value.

The researcher can finally assess the statistical significance regarding the new medication. A study result is statistically significant if the p-value of the data analysis is less than the prespecified alpha (significance level). In our example, the p-value is 0.02, which is less than the pre-specified alpha of 0.05, so the researcher concludes there is statistical significance for the study.

What does this mean? The p-value assumes the null hypothesis is true and provides the probability of results in excess as the ones observed IF the null hypothesis is true. The p-value is the probability based on the data assuming the null hypothesis is true. The p-value is not the probability of the null hypothesis itself. Remember, the null hypothesis states that there is no significant change in blood pressure if the patient is or is not taking the new medication. This is not the same as “a 2% chance” that the null hypothesis is correct. The researcher pre-specified an alpha of 0.05, implying they wanted the chance of the null hypothesis to be less than 5% before rejecting the null hypothesis. As the p-value is 0.02 and less than the alpha of 0.05, the researcher rejects the null hypothesis because there is statistical significance. By rejecting the null hypothesis, the researcher accepts the alternative hypothesis. The researcher rejects the idea that there is no difference in systolic blood pressure with the new medication and accepts the alternative that there is a difference of at least 10 mmHg in systolic blood pressure when taking the new medication.

If the researcher had prespecified an alpha of 0.01, implying they wanted to be 99% sure the new medication lowered the blood pressure by at least 10 mmHg, then the p-value of 0.02 would be greater than the prespecified alpha of 0.01. The researcher would conclude the study did not reach statistical significance as the p-value is equal to or greater than the pre-specified alpha. The research would then not be able to reject the null hypothesis.

## Function

A study is statistically significant if the p-value is less than the pre-specified alpha. Stated succinctly:

- A p-value less than alpha is a statistically significant result
- A p-value greater than or equal to alpha is not a statistically significant result.

## Issues of Concern

There are a few issues of concern when looking at statistical significance. These issues include choosing the alpha, statistical analysis method, and clinical significance.

Many current research articles specify an alpha of 0.05 for their significance level. It can not be stated strongly enough that there is nothing special, mathematical, or certain about picking an alpha of 0.05. Historically, the originators concluded that for many applications, an alpha of 0.05 or a one in 20 chance of being incorrect was good enough. It is imperative for the researcher to consider what their confidence level should truly be for the research question they are asking. Many times a smaller alpha, say of 0.01, may be more appropriate.

When creating a study, the alpha, or confidence level, should be specified before any intervention or collection of data. It is easy for a researcher to "see what the data shows" then pick an alpha to give a statistically significant result. Such approaches compromise the data and results as the researcher is more likely to be lax on confidence level selection to obtain a result that looks statistically significant.

A second important issue is selecting the correct statistical analysis method. There are numerous methods for obtaining a p-value. The method chosen depends on the type of data, the number of data points, and the question being asked. It is important to consider these questions during the study design so the statistical analysis can be correctly identified before the research. The statistical analysis method can then help determine how to collect the data correctly as well as the number of data points needed. If the wrong statistical method is used, the results may be meaningless as an incorrect p-value would be calculated.

## Clinical Significance

There is a key distinction in statistical significance versus clinical significance. Statistical significance determines if there is mathematical significance to the analysis of the results. Clinical significance means the difference is important to the patient and the clinician. In our study, the statistical significance would be present as the p-value was less than the pre-specified alpha. The clinical significance would be the 10 mmHg drop in systolic blood pressure.[6]

Two studies can have a similar statistical significance but vastly differ in clinical significance. Let us use a hypothetical example of two new chemotherapy agents for treating cancer. Drug A was found to increase survival by at least ten years with a p-value of 0.01 and alpha for the study of 0.05. Thus, this study has statistical significance (p-value less than alpha) and clinical significance (increased survival by ten years). A second chemotherapy agent, Drug B, is found to increase survival by at least 10 minutes with a p-value of 0.01 and alpha for the study of 0.05. The study for Drug B also found statistical significance (p-value less than alpha) but no clinical significance (a 10-minute increase in life expectancy is not clinically significant). In a separate study, those taking Drug A lived on average eight years after starting the medication versus living for only two more years on average for those not taking Drug A with a p-value of 0.08 and alpha for this second study of Drug A of 0.05. In this second study of Drug A, there is no statistical significance (p-value greater to or equal alpha).

## Enhancing Healthcare Team Outcomes

Each member of the health care team needs at least a basic understanding of statistical significance as research throughout all reams, from nursing to surgeons, pharmacists to social workers and all members in between have copious literature with conclusions based on statistical significance. If team members do not have a cohesive and congruent understanding of the statistical significance and its implications for research studies and findings then various members may draw opposing conclusions from the same research.

## References

- 1.
- Hayat MJ. Understanding statistical significance. Nurs Res. 2010 May-Jun;59(3):219-23. [PubMed: 20445438]
- 2.
- Mondal H, Mondal S. Statistical Significance is Prerequisite in Study. J Clin Diagn Res. 2017 Sep;11(9):CL01. [PMC free article: PMC5713722] [PubMed: 29207700]
- 3.
- Heston TF, King JM. Predictive power of statistical significance. World J Methodol. 2017 Dec 26;7(4):112-116. [PMC free article: PMC5746664] [PubMed: 29354483]
- 4.
- Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc. 2007 Nov;82(4):591-605. [PubMed: 17944619]
- 5.
- Haig BD. Tests of Statistical Significance Made Sound. Educ Psychol Meas. 2017 Jun;77(3):489-506. [PMC free article: PMC5965554] [PubMed: 29795925]
- 6.
- Jiménez-Paneque R. The questioned p value: clinical, practical and statistical significance. Medwave. 2016 Sep 09;16(8):e6534. [PubMed: 27636600]
- 7.
- Mariani AW, Pêgo-Fernandes PM. Statistical significance and clinical significance. Sao Paulo Med J. 2014;132(2):71-2. [PubMed: 24714985]

- Qualitative Study.[StatPearls. 2023]Qualitative Study.
*Tenny S, Brannan JM, Brannan GD.**StatPearls. 2023 Jan* - Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.[Cochrane Database Syst Rev. 2022]Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
*Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, et al.**Cochrane Database Syst Rev. 2022 Feb 1; 2(2022). Epub 2022 Feb 1.* - Medical Error Reduction and Prevention.[StatPearls. 2023]Medical Error Reduction and Prevention.
*Rodziewicz TL, Houseman B, Hipskind JE.**StatPearls. 2023 Jan* - Review Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.[Scand J Work Environ Health. 2...]Review Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
*Reuter M, Rigó M, Formazin M, Liebers F, Latza U, Castell S, Jöckel KH, Greiser KH, Michels KB, Krause G, et al.**Scand J Work Environ Health. 2022 Sep 1; 48(7):588-590. Epub 2022 Sep 25.* - Review [The uncertainties of statistical "significance"].[Rev Med Chil. 2018]Review [The uncertainties of statistical "significance"].
*Domenech RJ.**Rev Med Chil. 2018 Dec; 146(10):1184-1189.*

- Statistical Significance - StatPearlsStatistical Significance - StatPearls

Your browsing activity is empty.

Activity recording is turned off.

See more...